The assessment of eosinophilic chronic rhinosinusitis (eCRS) lacks accurate non-invasive preoperative prediction methods, relying primarily on invasive histopathological sections. This study aims to use computed tomography (CT) images and clinical parameters to develop an integrated deep learning model for the preoperative identification of eCRS and further explore the biological basis of its predictions. A total of 1098 patients with sinus CT images were included from two hospitals and were divided into training, internal, and external test sets. The region of interest of sinus lesions was manually outlined by an experienced radiologist. We utilized three deep learning models (3D-ResNet, 3D-Xception, and HR-Net) to extract features from CT images and calculate deep learning scores. The clinical signature and deep learning score were inputted into a support vector machine for classification. The receiver operating characteristic curve, sensitivity, specificity, and accuracy were used to evaluate the integrated deep learning model. Additionally, proteomic analysis was performed on 34 patients to explore the biological basis of the model's predictions. The area under the curve of the integrated deep learning model to predict eCRS was 0.851 (95% confidence interval [CI]: 0.77-0.93) and 0.821 (95% CI: 0.78-0.86) in the internal and external test sets. Proteomic analysis revealed that in patients predicted to be eCRS, 594 genes were dysregulated, and some of them were associated with pathways and biological processes such as chemokine signaling pathway. The proposed integrated deep learning model could effectively predict eCRS patients. This study provided a non-invasive way of identifying eCRS to facilitate personalized therapy, which will pave the way toward precision medicine for CRS.

We aimed to prospectively investigate whether bladder volume measured using deep learning artificial intelligence (AI) algorithms (AI-BV) is more accurate than that measured using conventional methods (C-BV) if using a portable ultrasound bladder scanner (PUBS). Patients who underwent filling cystometry because of lower urinary tract symptoms between January 2021 and July 2022 were enrolled. Every time the bladder was filled serially with normal saline from 0 mL to maximum cystometric capacity in 50 mL increments, C-BV was measured using PUBS. Ultrasound images obtained during this process were manually annotated to define the bladder contour, which was used to build a deep learning AI model. The true bladder volume (T-BV) for each bladder volume range was compared with C-BV and AI-BV for analysis. We enrolled 250 patients (213 men and 37 women), and a deep learning AI model was established using 1912 bladder images. There was a significant difference between C-BV (205.5 ± 170.8 mL) and T-BV (190.5 ± 165.7 mL) (p = 0.001), but no significant difference between AI-BV (197.0 ± 161.1 mL) and T-BV (190.5 ± 165.7 mL) (p = 0.081). In bladder volume ranges of 101-150, 151-200, and 201-300 mL, there were significant differences in the percentage of volume differences between [C-BV and T-BV] and [AI-BV and T-BV] (p < 0.05), but no significant difference if converted to absolute values (p > 0.05). C-BV (R² = 0.91, p < 0.001) and AI-BV (R² = 0.90, p < 0.001) were highly correlated with T-BV. The mean difference between AI-BV and T-BV (6.5 ± 50.4) was significantly smaller than that between C-BV and T-BV (15.0 ± 50.9) (p = 0.001). Following image pre-processing, deep learning AI-BV more accurately estimated true BV than conventional methods in this selected cohort on internal validation. Determination of the clinical relevance of these findings and performance in external cohorts requires further study. The clinical trial was conducted using an approved product for its approved indication, so approval from the Ministry of Food and Drug Safety (MFDS) was not required. Therefore, there is no clinical trial registration number.

Deep learning (DL) models for accurate renal tumor characterization may benefit from multi-center datasets for improved generalizability; however, data-sharing constraints necessitate privacy-preserving solutions like federated learning (FL). To assess the performance and reliability of FL for renal tumor segmentation and classification in multi-institutional MRI datasets. Retrospective multi-center study. A total of 987 patients (403 female) from six hospitals were included for analysis. 73% (723/987) had malignant renal tumors, primarily clear cell carcinoma (n = 509). Patients were split into training (n = 785), validation (n = 104), and test (n = 99) sets, stratified across three simulated institutions. MRI was performed at 1.5 T and 3 T using T2-weighted imaging (T2WI) and contrast-enhanced T1-weighted imaging (CE-T1WI) sequences. FL and non-FL approaches used nnU-Net for tumor segmentation and ResNet for its classification. FL-trained models across three simulated institutional clients with central weight aggregation, while the non-FL approach used centralized training on the full dataset. Segmentation was evaluated using Dice coefficients, and classification between malignant and benign lesions was assessed using accuracy, sensitivity, specificity, and area under the curves (AUCs). FL and non-FL performance was compared using the Wilcoxon test for segmentation Dice and Delong's test for AUC (p < 0.05). No significant difference was observed between FL and non-FL models in segmentation (Dice: 0.43 vs. 0.45, p = 0.202) or classification (AUC: 0.69 vs. 0.64, p = 0.959) on the test set. For classification, no significant difference was observed between the models in accuracy (p = 0.912), sensitivity (p = 0.862), or specificity (p = 0.847) on the test set. FL demonstrated comparable performance to non-FL approaches in renal tumor segmentation and classification, supporting its potential as a privacy-preserving alternative for multi-institutional DL models. 4. Stage 2.

Microvascular invasion (MVI) is strongly associated with the prognosis of patients with hepatocellular carcinoma (HCC). To evaluate the value of Transformer models with Sonazoid contrast-enhanced ultrasound (CEUS) in the preoperative prediction of MVI. This retrospective study included 164 HCC patients. Deep learning features and radiomic features were extracted from arterial and Kupffer phase images, alongside the collection of clinicopathological parameters. Normality was assessed using the Shapiro-Wilk test. The Mann‒Whitney U-test and least absolute shrinkage and selection operator algorithm were applied to screen features. Transformer, radiomic, and clinical prediction models for MVI were constructed with logistic regression. Repeated random splits followed a 7:3 ratio, with model performance evaluated over 50 iterations. The area under the receiver operating characteristic curve (AUC, 95% confidence interval [CI]), sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), decision curve, and calibration curve were used to evaluate the performance of the models. The DeLong test was applied to compare performance between models. The Bonferroni method was used to control type I error rates arising from multiple comparisons. A two-sided p-value of < 0.05 was considered statistically significant. In the training set, the diagnostic performance of the arterial-phase Transformer (AT) and Kupffer-phase Transformer (KT) models were better than that of the radiomic and clinical (Clin) models (p < 0.0001). In the validation set, both the AT and KT models outperformed the radiomic and Clin models in terms of diagnostic performance (p < 0.05). The AUC (95% CI) for the AT model was 0.821 (0.72-0.925) with an accuracy of 80.0%, and the KT model was 0.859 (0.766-0.977) with an accuracy of 70.0%. Logistic regression analysis indicated that tumor size (p = 0.016) and alpha-fetoprotein (AFP) (p = 0.046) were independent predictors of MVI. Transformer models using Sonazoid CEUS have potential for effectively identifying MVI-positive patients preoperatively.

Cortical regions such as parietal area H (PH) and the fundus of the superior temporal sulcus (FST) are involved in higher visual function and may play a role in dementia with Lewy bodies (DLB), which is frequently associated with hallucinations. The authors evaluated functional connectivity between these two regions for distinguishing participants with DLB from those with Alzheimer's disease (AD) or mild cognitive impairment (MCI) and from cognitively normal (CN) individuals to identify a functional connectivity MRI signature for DLB. Eighteen DLB participants completed cognitive testing and functional MRI scans and were matched to AD or MCI and CN individuals whose data were obtained from the Alzheimer's Disease Neuroimaging Initiative database (https://adni.loni.usc.edu). Images were analyzed with data from Human Connectome Project (HCP) comparison individuals by using a machine learning-based subject-specific HCP atlas based on diffusion tractography. Bihemispheric functional connectivity of the PH to left FST regions was reduced in the DLB group compared with the AD and CN groups (mean±SD connectivity score=0.307±0.009 vs. 0.456±0.006 and 0.433±0.006, respectively). No significant differences were detected among the groups in connectivity within basal ganglia structures, and no significant correlations were observed between neuropsychological testing results and functional connectivity between the PH and FST regions. Performances on clock-drawing and number-cancelation tests were significantly and negatively correlated with connectivity between the right caudate nucleus and right substantia nigra for DLB participants but not for AD or CN participants. The functional connectivity between PH and FST regions is uniquely affected by DLB and may help distinguish this condition from AD.

Artificial intelligence (AI) incorporation into healthcare has proven revolutionary, especially in radiotherapy, where accuracy is critical. The purpose of the study is to present patterns and develop topics in the application of AI to improve the precision of anatomical diagnosis, delineation of organs, and therapeutic effectiveness in radiation and radiological imaging. We performed a bibliometric analysis of scholarly articles in the fields starting in 2014. Through an examination of research output from key contributing nations and institutions, an analysis of notable research subjects, and an investigation of trends in scientific terminology pertaining to AI in radiology and radiotherapy. Furthermore, we examined software solutions based on AI in these domains, with a specific emphasis on extracting anatomical features and recognizing organs for the purpose of treatment planning. Our investigation found a significant surge in papers pertaining to AI in the fields since 2014. Institutions such as Emory University and Memorial Sloan-Kettering Cancer Center made substantial contributions to the development of the United States and China as leading research-producing nations. Key study areas encompassed adaptive radiation informed by anatomical alterations, MR-Linac for enhanced vision of soft tissues, and multi-organ segmentation for accurate planning of radiotherapy. An evident increase in the frequency of phrases such as 'radiomics,' 'radiotherapy segmentation,' and 'dosiomics' was noted. The evaluation of AI-based software revealed a wide range of uses in several subdisciplinary fields of radiation and radiology, particularly in improving the identification of anatomical features for treatment planning and identifying organs at risk. The incorporation of AI in anatomical diagnosis in radiological imaging and radiotherapy is progressing rapidly, with substantial capacity to transform the precision of diagnoses and the effectiveness of treatment planning.

This study aims to investigate the feasibility of a single general model to synthesize CT images across body sites, thorax, abdomen, and pelvis, to support treatment planning for MRI-only radiotherapy. A total of 157 patients who received MRI-guided radiation therapy in the thorax, abdomen, and pelvis on a 0.35T MRIdian Linac were included. A subset of 122 cases were used for model training and the remaining 35 cases were used for model validation. All patient datasets had semi-paired CT-simulation image and 0.35T MR image acquired using TrueFISP. A conditional generative adversarial network with a multi-planar method was used to generate synthetic CT images from 0.35T MR images. The effect of preprocessing methods (with and without bias field corrections) on the quality of synthetic CT was evaluated and found to be insignificant. The general models trained on all cases performed comparably to the site-specific models trained on individual body sites. For all models, the peak signal-to-noise ratios ranged from 31.7 to 34.9 and the structural index similarity measures ranged from 0.9547 to 0.9758. For the datasets with bias field corrections, the mean-absolute-errors in HU (general model versus site-specific model) were 49.7 ± 9.4 versus 49.5 ± 8.9, 48.7 ± 7.6 versus 43 ± 7.8 and 32.8 ± 5.5 versus 31.8 ± 5.3 for the thorax, abdomen, and pelvis, respectively. When comparing plans between synthetic CTs and ground truth CTs, the dosimetric difference was on average less than 0.5% (0.2 Gy) for target coverage and less than 2.1% (0.4 Gy) for organ-at-risk metrics for all body sites with either the general or specific models. Synthetic CT plans showed good agreement with mean gamma pass rates of >94% and >99% for 1%/1 mm and 2%/2 mm, respectively. This study has demonstrated the feasibility of using a general model for multiple body sites and the potential of using synthetic CT to support an MRI-guided radiotherapy workflow.

Oral cavity carcinomas (OCCs) represent roughly 50% of all head and neck cancers. The risk of occult neck metastases for early-stage OCCs ranges from 15% to 35%, hence the need to develop tools that can support the diagnosis of detecting these neck metastases. Machine learning and radiomic features are emerging as effective tools in this field. Thus, the aim of this study is to demonstrate the effectiveness of radiomic features to predict the risk of occult neck metastases in early-stage (T1-T2/N0) OCCs. Retrospective study. A single-institution analysis (Maxillo-facial Surgery Unit, University of Naples Federico II). A retrospective analysis was conducted on 75 patients surgically treated for early-stage OCC. For all patients, data regarding TNM, in particular pN status after the histopathological examination, have been obtained and the analysis of radiomic features from MRI has been extrapolated. 56 patients confirmed N0 status after surgery, while 19 resulted in pN+. The radiomic features, extracted by a machine-learning algorithm, exhibited the ability to preoperatively discriminate occult neck metastases with a sensitivity of 78%, specificity of 83%, an AUC of 86%, accuracy of 80%, and a positive predictive value (PPV) of 63%. Our results seem to confirm that radiomic features, extracted by machine learning methods, are effective tools in detecting occult neck metastases in early-stage OCCs. The clinical relevance of this study is that radiomics could be used routinely as a preoperative tool to support diagnosis and to help surgeons in the surgical decision-making process, particularly regarding surgical indications for neck lymph node treatment.

Understanding the impact of epilepsy on pediatric brain tumors is crucial to diagnostic precision and optimal treatment selection. This study investigated MRI radiomics features, tumor location, voxel-based morphometry (VBM) for gray matter density, and tumor volumetry to differentiate between children with low grade glioma (LGG)-associated epilepsies and those without, and further identified key radiomics features for predicting of epilepsy risk in children with supratentorial LGG to construct an epilepsy prediction model. A total of 206 radiomics features of tumors and voxel-based morphometric analysis of tumor location features were extracted from T2-FLAIR images in a primary cohort of 48 children with LGG with epilepsy (N = 23) or without epilepsy (N = 25), prior to surgery. Feature selection was performed using the minimum redundancy maximum relevance algorithm, and leave-one-out cross-validation was applied to assess the predictive performance of radiomics and tumor location signatures in differentiating epilepsy-associated LGG from non-epilepsy cases. Voxel-based morphometric analysis showed significant positive t-scores within bilateral temporal cortex and negative t-scores in basal ganglia between epilepsy and non-epilepsy groups. Eight radiomics features were identified as significant predictors of epilepsy in LGG, encompassing characteristics of 2 locations, 2 shapes, 1 image gray scale intensity, and 3 textures. The most important predictor was temporal lobe involvement, followed by high dependence high grey level emphasis, elongation, area density, information correlation 1, midbrain and intensity range. The Linear Support Vector Machine (SVM) model yielded the best prediction performance, when implemented with a combination of radiomics features and tumor location features, as evidenced by the following metrics: precision (0.955), recall (0.913), specificity (0.960), accuracy (0.938), F-1 score (0.933), and area under curve (AUC) (0.950). Our findings demonstrated the efficacy of machine learning models based on radiomics features and voxel-based anatomical locations in predicting the risk of epilepsy in supratentorial LGG. This model provides a highly accurate tool for distinguishing epilepsy-associated LGG in children, supporting precise treatment planning. Not applicable.

The standard approach to diagnosing idiopathic pulmonary fibrosis (IPF) includes identifying the usual interstitial pneumonia (UIP) pattern via high resolution computed tomography (HRCT) or lung biopsy and excluding known causes of interstitial lung disease (ILD). However, limitations of manual interpretation of lung imaging, along with other reasons such as lack of relevant knowledge and non-specific symptoms have hindered the timely diagnosis of IPF. This review proposes the definition of early IPF, emphasizes the diagnostic urgency of early IPF, and highlights current diagnostic strategies and future prospects for early IPF. The integration of artificial intelligence (AI), specifically machine learning (ML) and deep learning (DL), is revolutionizing the diagnostic procedure of early IPF by standardizing and accelerating the interpretation of thoracic images. Innovative bronchoscopic techniques such as transbronchial lung cryobiopsy (TBLC), genomic classifier, and endobronchial optical coherence tomography (EB-OCT) provide less invasive diagnostic alternatives. In addition, chest auscultation, serum biomarkers, and susceptibility genes are pivotal for the indication of early diagnosis. Ongoing research is essential for refining diagnostic methods and treatment strategies for early IPF.